Optogenetics is the combination of genetics and optics to control well-defined events within specific living cell tissue and relies on a new type of light-sensitive protein that can be embedded in neuron cell bodies, combined with holographic light-shaping that can focus light on a single cell. It includes the discovery and insertion into cells of genes that confer light responsiveness.
This article is a part of Patent Landscape report by PatSeer which analyzes the research trends of optogenetics with a focus on Targeting Techniques, Sensors, Light Equipments, Actuators and Applications and also highlights the key Applicants involved in this space.
Innovation Summary of Top Applicants:
The chart below shows innovation summary for the top 10 applicants:
- Bristol Myers has the largest portfolio but the overall invention age for its portfolio is more than 20 years
- Immunolight and Acucela are new challengers in the field of optogenetics
To know more about the Patent trends and innovation in Optogenetics visit — Patent Landscape Report on Optogenetics by PatSeer
